|
CN108285431A
|
|
Related substance of a kind of pirfenidone and its preparation method and application
|
|
CN101836973A
|
|
New application of amide compound
|
|
CN101723936A
|
|
Kinase suppressor and pharmaceutical application thereof
|
|
CN101723883A
|
|
Method for preparing oxycodone
|
|
CN101619345A
|
|
Application of NINJ1 protein in tumor treatment
|
|
CN101484167A
|
|
The use of derviate of pyridone for preventing and treating radioactive injury of lungs
|
|
CN101143214A
|
|
Important regulating gene RPS6KA2 for IL-2RG signal pathway
|
|
CN101112614A
|
|
Glair NRBP having important functions in regulating and controlling in immunoregulation
|
|
CN101041071A
|
|
Interacted proteins of APC10 and the function for adjusting the cell period thereof
|
|
CN1990860A
|
|
Important regulation kinase VRK2 interacted with MCL1
|
|
CN1952166A
|
|
Important controlling gene PIX in anti-tumor immunological reaction
|
|
CN1923276A
|
|
Important regulation protein PAK7 of NF[kappa]B signal path
|
|
CN1924015A
|
|
Important regulation albumen ChK2 of NF-KB signal path
|
|
CN1920014A
|
|
Phosphokinase PKD2 and application thereof
|
|
CN1884505A
|
|
Tumour related protein kinase RX17 and its uses
|
|
CN1701793A
|
|
The purposes of pirfenidone in the medicine of preparation treatment hepatic injury necrosis and acute lung injury
|
|
CA2545813A1
|
|
The derivatives of pyridone and use thereof
|
